Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Prepaid Assets: 2023-2025

Historic Prepaid Assets for Zenas BioPharma (ZBIO) over the last 1 years, with Sep 2025 value amounting to $5.8 million.

  • Zenas BioPharma's Prepaid Assets fell 17.50% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year decrease of 17.50%. This contributed to the annual value of $5.1 million for FY2024, which is 71.94% up from last year.
  • According to the latest figures from Q3 2025, Zenas BioPharma's Prepaid Assets is $5.8 million, which was up 8.15% from $5.3 million recorded in Q2 2025.
  • Zenas BioPharma's 5-year Prepaid Assets high stood at $7.0 million for Q3 2024, and its period low was $2.9 million during Q4 2023.
  • For the 3-year period, Zenas BioPharma's Prepaid Assets averaged around $5.3 million, with its median value being $5.4 million (2025).
  • Per our database at Business Quant, Zenas BioPharma's Prepaid Assets spiked by 71.94% in 2024 and then dropped by 17.50% in 2025.
  • Zenas BioPharma's Prepaid Assets (Quarterly) stood at $2.9 million in 2023, then soared by 71.94% to $5.1 million in 2024, then decreased by 17.50% to $5.8 million in 2025.
  • Its Prepaid Assets stands at $5.8 million for Q3 2025, versus $5.3 million for Q2 2025 and $5.4 million for Q1 2025.